 KANSAS CITY, Kan., May 18, 2022 GLOBE NEWSWIRE -- Cingulate Inc. NASDAQ: CING, a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed ReleaseTM PTRTM drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and Chief Executive Officer, Shane J. Schaffer, and Chief Medical Officer, Matthew Brams, M.D., will present a company overview at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022, from 3:00-3:30 p.m. ET, at the Fontainebleau Miami Beach Hotel, Miami, FL. 